Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cspc Mingfule Pharmaceutical (guangzhou) Co., Ltd.

Clinical trials sponsored by Cspc Mingfule Pharmaceutical (guangzhou) Co., Ltd., explained in plain language.

Now part of CSPC Pharmaceutical Group Limited 1093 HKEX

A pharmaceutical subsidiary of CSPC Pharmaceutical Group.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1

New Clot-Buster may be safer for stroke patients

Disease control Not yet recruiting

This study will compare the safety of two clot-dissolving drugs, rhTNK-tPA and rt-PA, in 4500 adults having an acute ischemic stroke. Researchers will track how often each drug causes serious bleeding in the brain within 36 hours. The goal is to see if the newer drug, rhTNK-tPA, …

Sponsor: CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC